Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression data of organoid derived from HSCs

ABSTRACT: Expression data of organoid derived from HSCs

PROVIDER: PRJNA496603 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression data of organoid derived from HSCs

Project description:To investigate the differences in mRNA expression profiles between TSG-6 or vehicle treated Hu-pHSCs and BM-MSCs organoid spheroids, we performed mRNA microarrays for total RNA extracts isolated from these spheroids (vehicle: CON/3D=3, TSG6: TSG-6/3D=4, BM: BM-MSCs3D=3) We used microarrays to detail the global programme of gene expression underlying cellularisation and identified distinct classes of up-regulated genes during this process.

2021-10-16 | GSE121298 | GEO

Gene Expression data of MTA1-deficient human cord blood-derived HSCs

Project description:Gene Expression data of MTA1-deficient human cord blood-derived HSCs

| PRJNA849156 | ENA

several colorectal cancer patient derived tumor organoid RNAseq data

Project description:several colorectal cancer patient derived tumor organoid RNAseq data

| PRJNA1021206 | ENA

Bulk RNA-seq of MilliporeSigma 3DGro human patient-derived gastrointestinal organoid lines compared to SCC300 human iPSC-derived colon organoid line

Project description:Transcriptomic profiles of 6 commercially-available human patient-derived gastrointestinal organoid lines were obtained and compared to transcriptomic profile of a commercially available human iPSC-induced colon organoid line. Transcriptomic profile of iPSC-derived human colon organoid line was compared after culture in either Corning growth-factor-reduced Matrigel (Corning 356231) or MilliporeSigma growth-factor-reduced ECMGel (E6909)

2022-03-31 | E-MTAB-11557 | biostudies-arrayexpress

Gene Expression data human HSCs with 2-LSD1 inhibitors

Project description:Gene Expression data human HSCs with 2-LSD1 inhibitors

| PRJNA548913 | ENA

Gene expression profiles in human duodenal organoid-derived monolayer

Project description:Gene expression profiles in human duodenal organoid-derived monolayer

| PRJNA674027 | ENA

Gene expression profiles in human liver organoid-derived hepatocytes

Project description:Gene expression profiles in human liver organoid-derived hepatocytes

| PRJNA981479 | ENA

Gene expression profiling of LT-HSCs and ST-HSCs conditionally expressing MLL-ENL

Project description:We have developed a new conditional transgenic mouse showing that MLL-ENL, at an endogenous-like expression level, induces leukemic transformation selectively in LT-HSCs. To investigate the molecular mechanism of leukemic transformation in LT-HSCs conditionally expressing MLL-ENL, we preliminarily performed comprehensive gene expression profiling of CreER-transduced LT-HSCs and ST-HSCs using cDNA microarray analysis. For initial screening of candidate genes invloved in the leukemic transformation, total RNA was extracted from colony-forming cells derived from LT-HSCs and ST-HSCs transduced with CreER or mock. Four samples were analyzed, and CreER-transduced LT/ST-HSC-derived cells were compared with mock-transduced LT/ST-HSC-derived cells, while CreER/mock-transduced LT-HSC-derived cells were compared with CreER/mock-transduced ST-HSC-derived cells.

2013-07-17 | E-GEOD-48539 | biostudies-arrayexpress

Expression data from HSCs

Project description:Hepatic stellate cells (HSCs) experience phenotypic transformation, from the quiescent phenotype to the activated one, after different etiologies of liver injury. Liver fibrosis is then occurred upon the activation of HSCs. miR-16 deficiency is identified to be an important characteristic of HSCs activation. We used Affymetrix rat 230 2.0 arrays (Affymetrix, Santa Clara, U.S.A.) to uncover the global alternations of transcriptome under miR-16 restoration. We isolated quiescent hepatic stellate cells (HSCs) from adult male SD rats (normal control group) by in situ perfusion and density-gradient centrifugation. Activated HSCs were separated from rats of fibrosis model group, which were treated by 40% carbon tetrachloride (CCl4) for 8 weeks, by means of liver section, digestion and sequential centrifugation. Quiescent and activated HSCs were then divided into 4 groups at random, namely quiescent HSCs, activated HSCs, pLV-miR-16-treated HSCs and pLV-GFP-treated HSCs. The pLV-miR-16-treated group, pLV-GFP-treated group were infected with pLV-miR-16 and pLV-GFP, respectively.

2012-08-28 | E-GEOD-40381 | biostudies-arrayexpress

Patient-derived breast cancer organoid study

Project description:Patient-derived breast cancer organoid study

| PRJNA786253 | ENA